Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers by Gitte Borup et al.
:2Borup et al. Harm Reduction Journal 2015, 12
http://www.harmreductionjournal.com/content/12/1/2RESEARCH Open AccessExploratory survey study of long-term users of
nicotine replacement therapy in Danish consumers
Gitte Borup1*, Kim Lyngby Mikkelsen2, Philip Tønnesen3 and Lona Louring Christrup1Abstract
Background: Long-term use of nicotine replacement therapy (NRT) has been approved in several countries for smokers
who are unable or unwilling to quit smoking. However, information on basic characteristics, degree of nicotine
dependence, health status and contentment with long-term use of NRT is scarce. The aim of this study was to
collect information on the characteristics of long-term NRT users, having used NRT for at least 12 months, reasons
for, and contentment with, their continued use of NRT including reasons for wishing to quit or sustain use and
an estimation of their degree of nicotine dependence.
Method: Through advertisements in three national Danish newspapers, long-term NRT users were recruited to
answer a short questionnaire about basic characteristics, health status and satisfaction with using NRT. A modified
version of the Heaviness of Smoking Index (HSI) questionnaire was applied to estimate nicotine dependence. Linear
regression was used to test association between time to first NRT and daily dosage of NRT.
Results: A total of 92 respondents were included in the data analysis. A majority of 88% wished to quit NRT for the
following reasons: costs of NRT, being tired of feeling addicted and fear of adverse health effects. Scoring on the
modified HSI scale was 22.0% low, 68.0% moderate and 9.3% high dependent. Of the respondents, 67.0% used NRT
within the first 30 min after waking. A validation check found a significant linear association between the two items in
the modified HSI.
Conclusion: A significant majority of users wished to quit NRT because of the cost of products, being tired of feeling
addicted and fear of adverse health consequences. The majority of these users were moderate to high nicotine
dependent. The strong association found between time to first NRT and NRT dosages used per day gives reason
to believe the validity of the modified HSI. Further studies are required for confirmation. Better counselling of
long-term users on the benefits of using NRT compared to smoking should be provided, for those who are chronically
dependent, as well as support to stop long-term use of NRT if wanted.
Keywords: Nicotine replacement therapy, NRT, Long-term use, Nicotine dependence, Modified Heaviness of Smoking
Index, Survey research, User perspectiveBackground
Results from a national survey on smoking habits, con-
ducted in 2012 on a representative segment of adults in
Denmark (DK), indicated that among respondents using
nicotine replacement therapy (NRT), 48% (66 out of 138)
had used the products for more than 12 months [1] being
equivalent to 1.3% of the total adult population in DK.
When NRT first became available, the recommended
duration of treatment was up to 3 months after smoking© 2015Borup et al.; licensee BioMed Central. T
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unless otherwise stated.cessation for most products, since this was the duration of
use in most clinical trials designed to determine efficacy
and safety of NRTs [2]. The indications of most NRT
products have since been extended to include concurrent
use while smoking and allow for longer durations of treat-
ment, as it was recognised that this would benefit the
more dependent smokers in succeeding in quitting [3]. In
the literature, the definition of long-term use of NRT
ranges from 3 to 12 months [4-7]. In this study, long-term
use is defined as the daily use of NRT for 12 months or
more, which is the current longest recommended durationhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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for nicotine gum in DK.
Reports on the incidence of becoming a long-term user
of NRT following smoking cessation attempts vary from
1% in real life settings [8] up to 25% of the successful
abstainers participating in clinical trials on smoking
cessation [9-12]. Generally, smokers enrolled in smoking
cessation studies have higher levels of nicotine depend-
ence than the average smokers in the general population
and thus have a greater likelihood of becoming long-term
users of NRT [5-7,10].
Initially, long-term use of NRT was viewed as problem-
atic because of concerns about possible adverse health
consequences caused by nicotine [13,14]. Some research
has indicated that NRT can worsen insulin resistance and
prevent the normalisation of cholesterol levels, otherwise
obtained following smoking cessation [15-17], but to
this date, no serious adverse effects have been reported.
Also, no causality between acute cardiovascular episodes
in high-risk populations and the use of NRT has been
found [18]. In fact, long-term use of NRT and other non-
combustible tobacco products are advocated for as a way
of harm reduction for smokers who are incapable or
unwilling to quit smoking [5,8,19-22]. Current smoker
precautions to using NRT long-term include cost, fear-
ing becoming addicted to NRT and fearing potential ad-
verse health effects [23]. However, results from previous
research have shown that smokers are willing to use NRT
with the goal of either reducing or quitting smoking, or
as a possible long-term substitute for cigarettes, when
the health advantages compared to smoking have been
explained to them [22,24-29]. Results from an internet
survey of nicotine gum users, where long-term use was
defined as gum use for more than 3 months, suggested
that users scoring high on modified nicotine depend-
ence scales were less likely to have quit using NRT at
follow-up 1 month later and that 75.6% of the long-term
users felt unable to quit using nicotine gum [4].
The purpose of the present study was therefore to col-
lect information on the characteristics of long-term NRT
users, that had used NRT for more than 12 months, rea-
sons for their continued use of NRTand contentment with
being long-term users of NRT, including reasons for wish-
ing to quit or sustain use. Furthermore, the collected data
gave us the opportunity to estimate the degree of nicotine
dependence in the long-term users and make a validation




Advertisements were posted in three national newspapers
for 1 day, seeking daily users of NRT to participate in the
survey. Respondents should either be former or currentsmokers, have used NRT for more than 12 months and be
at least 18 years of age. Simultaneously with the printed
ad, an online banner was run for 14 days on two of the
newspapers’ online versions from where the respondents
could complete the questionnaire directly. Participation
gave an opportunity to win one of five gift vouchers of 500
DKK (70 Euros). The survey was run in two parts, the first
two advertisements in November 2012 and the second in
January 2013. The investigation was approved by the
Danish Data Protection Agency. The participants where
informed that they could discontinue their participation
at any point, and have their answers withdrawn from the
investigation. Only answers from completed question-
naires were included in the results.
Questionnaire and ratings
The questionnaire covered basic demographics, current
use of NRT products, reasons for using NRT, reason for
wishing to quit or sustain NRT use, present and former
smoking history, whether or not respondents had been
encouraged to quit smoking, received advice on correct
use of NRT, health status and contact information if the
respondents wished to participate in a future interview in-
vestigation, regarding their experience as long-term NRT
users. In the second round, one question was added to the
survey, asking former smokers if they believed that they
would relapse to smoking if NRT where no longer available
[30]. Although e-cigarettes are not medicinal products, it
was possible for the respondents to choose e-cigarettes
when asked about their NRT products of choice. The argu-
ment for including e-cigarettes was a presumption that the
general population, to some extent, does not differentiate
between NRT and e-cigarettes as aids for quitting smoking.
E-cigarettes were not mentioned in the wording of the
advertisement, but when filling in the questionnaire, re-
spondents had the opportunity to select e-cigarette as
their nicotine source, leaving it to the respondent to de-
fine e-cigarettes as NRT or not.
To evaluate degree of nicotine dependence, a modified
version of the HSI scale was used, where pieces of acute-
acting single-dose NRT was substituted for cigarettes in
a 1:1 fashion. The HSI is a two-item questionnaire [31]
that is based on the Fagerström test for Nicotine Depend-
ence (FTND) [32]. The outcome of HSI, in association
with smoking, has been found to correlate highly with
biochemical dependence measures [33] and to be a strong
predictor of abstinence outcomes as well as predictors of
tendency to relapse [31,34]. The HSI comprises a question
about “time to first cigarette in the morning” that has been
found to be a reliable single measure of nicotine depend-
ence [34], which was therefore analysed independently. The
second question was “use of pieces of NRT per day”.
The categorization of NRT use was done subsequently.
The modified HSI score was calculated as the sum score
http://www.harmreductionjournal.com/content/12/1/2
Table 1 Basic characteristics, smoking history and current
NRT use
Total of respondents (n = 92)
Men (%, N) 45.7 (42)
Mean age (SD, range) 52.0 (10.6, 33–75)
Mean duration of NRT use in years (SD, range) 5.5 (4.5, 1–27)
Mean current NRT useab (SD, range) 15.0 (9.4, 3–60)
Mean former smoking years (SD, range) 27.4 (11.5, 5–53)
Mean recalled smokingc (SD, range) 19.5 (8. 38, 5–60)
Wish to quit NRT (%, N) 88.0 (81)
Felt addicted to NRT (%, N) 77.2 (71)
aIncluding respondents using only acute single-dose NRT.
bExpressed as NRT pieces/day.
cExpressed as cig/day.
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were categorised as low (0–1 points), moderate (2–4 points)
and high (5–6 points) [35].
Statistics
To undertake a validation check of the HSI scale, a linear
regression was used in order to assert a negative associ-
ation and to measure the strength of association between
time to first NRT (TTFN) and NRT use (pieces/day) and
between TTFN and recalled smoking (cig/day). TTFN was
categorised in four groups and used as an explanatory
variable, either as a categorical variable with group A as
the reference group or as a continuous variable. The likeli-
hood ratio test was used to test for linear trend, comparing
models with TTNF used as a categorical variable and
with TTNF used as a continuous variable. Linear regres-
sion was also used to find the equivalence ratio between
daily NRT use (NRT pieces/day) and recalled smoking
(cig/day). Fractional polynomial regression was used to
give a graphical check of the association. As there was
clearly a non-linear association, the analysis was done sep-
arately for individuals with a smoking history less or equal
to 25 cig/day and for individuals with a smoking history of
more than 25 cig/day. In this analysis, the delta-beta influ-
ence statistics was used to identify outliers. Delta-beta is
the difference between the regression coefficient when the
jth observation is included and excluded. Observations
were excluded if delta-beta was >5 standard deviation. A
significance level of 0.05 was used in all tests. All statistical
analyses were done using Stata 13.1 (StataCorp, 4905
Lakeway Drive, College Station, TX 77845 USA).
Results
A total of 112 respondents completed the questionnaire,
95 former smokers, 17 current smokers and 1 never smoker.
Data from current smokers was not included in the
data analyses. Data from additionally 3 respondents
were excluded from the analyses: 1 never smoker, 1
who had quit using NRT 3 years previously and 1 being a
former pipe smoker.
Characteristics of respondents
Respondent characteristics are listed in Table 1. The most
common NRT product used by the participants’ was nico-
tine chewing gum 2 mg (67.4%, N = 62), followed by 4 mg
gum (12.0%, N = 11) and inhaler (9.8%, N = 9). Other
products used were lozenges, e-cigarettes and chewing
tobacco. Thirteen respondents combined two or more
products. Four of the respondents (4.3%) used nicotine
patches in combination with an acute-acting NRT. Some
respondents stated their former daily cigarette use in in-
tervals, e.g. 15–20. In these cases, the average of the inter-
val given was used in the data analysis.When asked to elaborate in their own words why they
wished to quit using NRT, the primary causes stated were
1) being tired of feeling addicted to NRT (51.1%, N = 45)
2) cost of NRT products (50.0%, N = 44) and 3) fear of ad-
verse health effects (40.9%, N = 36). The respondents not
wishing to quit (N = 12) stated that they believed NRT to
be less hazardous to their health than cigarettes (N = 7),
that NRT prevented them to relapse to smoking (N = 7)
and that they enjoyed using NRT (N = 7). The average
NRT use per day, based on those only using acute-acting
single-dose NRT (N = 75), was for those not wishing to
quit 11.3 NRT pieces/day (N = 8) and for those wishing to
quit 15.5 NRT pieces per day (N = 67).
Assessment of nicotine dependence
Nicotine dependence scores from the modified HSI were
assessed only in respondents using acute-acting single-
dose NRT (N = 75). The modified HSI was calculated from
current NRT use and time to first NRT after waking in the
morning (TTFN). It was found that 22.7% of the respon-
dents were low nicotine dependent (N = 17), 68.0% were
moderately dependent (N = 51) and 9.3% highly dependent
(N = 7) (Table 2). The respondents who were highly
dependent used a mean of 35.9 NRT pieces/day, the
moderately dependent used an average of 14.3 NRT
pieces/day and the low dependent used a mean of 8.7
NRT pieces/day.
Of all respondents using acute-acting NRT (N = 88)
(patch users omitted N = 4), 67.0% (N = 49) stated a TTFN
of 30 min or less. Again, of those using only acute-acting
NRT (N = 75), 65.3% (N = 49) used NRT before 30 min
after waking, using an average of 17.6 (SD = 10.3, range
5–60) NRT pieces/day. Those using NRT later during the
day (N = 26) used an average of 10.2 (SD = 4.3, range
3–20) NRT pieces/day.
The strength and direction of the association between
TTFN and amount of NRT pieces per day is shown in
Table 3. The test for linear trend showed that the linear
Table 2 Classification of dependence according to the Heaviness of Smoking Index (HSI score)
A = 3 points (0–5 min) B = 2 points (6–30 min) C = 1 point (31–60 min) D = 0 points (later)
A = 0 points (≤10) 4 8 6b 8b
B = 1 point (11–20) 15 10 9 3b
C = 2 points (21–30) 4a 5 - -
D = 3 points (31 ≤) 2a 1a - -
The classification of dependence includes respondents using only acute-acting single-dose NRT. Patch, e-cigarette and inhaler users were omitted (n = 75). The time
intervals in the columns indicate time to first NRT after waking. The intervals given in the rows indicate number of NRT doses per day.
aHighly nicotine dependent respondents (score 5–6) = 9.3% (N = 7).
bRespondents found low dependent on nicotine (score 0–1) = 22.7% (N = 17). Respondents moderately dependent on nicotine (score 2–4) = 68.0% (N = 51).
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ratio test: p = 0.23). For every category of delayed NRT
use after waking, the average number of NRT pieces/day
was reduced with 3.6 (95% CI −5.53 to −1.70) showing a
highly significant association between TTFN and NRT
use. Linear regression of recalled smoking with cig/day
explained by TTFN (likelihood ratio test = 0.38) showed
that cig/day was reduced by 2.77 per category of TTFN
(95% CI −4.42 to −1.13).Equivalence ratio between current NRT pieces/day and
recalled cig/day
The correlation between current NRT use and recalled
smoking was low and insignificant (r = 0.18, p = 0.12) in-
dicating that the association was also not linear for the
full range of the data. Fractional polynomial regression
showed that the association varied by the number of
recalled cig/day, with a constant increasing equivalence
ratio up to a maximum at approximately 25 cig/day and
levelling off at higher recalled use. The linear regression
of NRT use on recalled smoking (Figure 1) showed an
equivalence ratio of 0.86 NRT/cig (95% CI 0.730 to 0.98,
N = 64) for individuals with a smoking history of up to
25 (cig/day). No significant association for individuals with
a smoking history of more than 25 (cig/day) (95% CI 11.9
to 20.1) could be demonstrated.Table 3 Time to first NRT compared to mean current NRT









0-5 min 33.3 (25) 19.1 (11.6) 22.2 (10.8)
6-30 min 32.0 (24) 16.1 (9.0) 20.4 (5.2)
31-60 min 20.0 (15) 11.2 (3.2) 17.4 (5.4)
Later 16.0 (11) 8.8 (5.5) 13.1 (5.1)
Includes respondents using only acute-acting single-dose NRT (n = 75). Respondents
using patch, e-cigarette and inhaler were omitted. For every category of delayed
NRT use after waking, the average number of NRT pieces/day was reduced to 3.6
(95% CI −5.53 to −1.70) showing a highly significant association between TTFN
and NRT use.Discussion
Respondent characteristics
The characteristics of the respondents were found to be
similar to the respondents in earlier studies on long-term
NRT users [4,5,7] with regard to mean age, mean NRT
use and duration of use, regardless that these studies had
different inclusion criteria. Still, the generalizability of the
characteristics found in this study cannot be validated.
Long-term users of NRT who are concerned of or dis-
pleased with their NRT use may be more aware of news
concerning NRT and thus more likely to participate in
surveys on NRT resulting in an overrepresentation bias
of this group, opposed to long-term users, who willingly
continue using NRT [36].
Dependence on nicotine in former smokers
When estimated from the modified HSI, including respon-
dents using only acute-acting single-dose NRT (N = 75),
22% were found to rate low in nicotine dependence, 68.0%
to rate moderate in dependence and 9.3% to rate high in
dependence. Among Danish daily smokers, approximately
30% are estimated to be low dependent, 61% moderate
dependent and 9% high dependent [37]. This might imply
that smokers do not generally become more dependent on
nicotine when switching to NRT than they were when still
actively smoking. An explanation for the slightly lower
proportion of low-dependent NRT users (22%), seen in
this study compared to low-dependent smokers (30%)
in the report by Glümer et al. [37], might be that low-
dependent smokers succeed in quitting without becom-
ing long-term users of NRT or that they quit smoking
unaided.
The behavioural item of the HSI: how soon after waking
smokers have their first cigarette (TTFN), has been
suggested as a possible single-item measure of nicotine de-
pendence, as time to first cigarette is highly negatively cor-
related to the full FTND scale [34]. When looking at
TTFN, 67.4% of the respondents used NRT within the first
30 min after waking, almost equalling the moderate- and
high-dependent users combined from the modified HSI.
The negative and strong association between TTFN and
NRT use found in the present study gives reason to
2015,
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Figure 1 Equivalence ratio between current NRT use and recalled smoking. The regression line is based on a fractional polynomial regression
and includes respondents using acute-acting single-dose NRT (N = 75). One outlier with high recalled cig/day and low NRT pieces/day was omitted
(delta-beta = −8.1 SD). Logistic regression up to and including 25 cig/day showed a significant equivalence ratio of 0.86. No significance was found
for those with recalled smoking of more than 25 cig/day.
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validation studies are needed for confirmation.
Applicability of the heaviness of smoking index
When comparing smoking history in the following con-
text, a caveat on bias in regard to the recalled smoking
history must be emphasised. First, when asking respon-
dents to recall habits exercised several years earlier, the ac-
curacy of the recollected habits may be uncertain. Second,
several respondents stated an interval of former average
cigarette use, e.g. 15–20 cig/day from where an average
was used.
However, assuming that the information on average
cigarette consumption was accurate, regression analysis
showed a reduction in NRT use (pieces/day) of 0.86:1
when compared to recalled smoking (cig/day). An upper
limit of daily NRT use seemed to be present at 20 NRT
pieces/day, with only eight respondents using more. The
decreased use of NRT, as compared to the former daily
cigarette use, has several plausible explanations. First,
as earlier suggested by Cinciripini et al., the current NRT
habits, may have replaced only the high-preference smok-
ing moments, omitting the low-preference moments [38].
This underscores that the use of NRT at a lower rate
compared to former smoking is not merely habitual,
but instead driven by dependence. Second, when using
nicotine gum, a physical limitation of jaw pain from
constant chewing may also limit the daily consumption
[39]. Third, the average recalled smoking history was on
average 19.5 (cig/day) equalling the size of cigarette packets,
and the average NRT use was 15.0 (pieces/day) equallinga blister pack of nicotine chewing gum. Some former
smokers may therefore simply have adjusted their habits
of one cigarette packet a day to one blister pack a day.
Also, no distinction was made between the strength of
the acute-acting NRT products used by the respondents
or the products different nicotine uptake profiles, when
estimating nicotine dependence. This would have contrib-
uted to a more precise estimation of nicotine dependence,
but it would also have demanded further explanations
from the participants on how they use the products, and
whether or not they used them correctly. For instance,
some long-term users may purchase 4 mg chewing gum
and use 10 pieces/day, but instead of using them as
intended, they may in fact divide each piece into halves
obtaining 20 2 mg pieces/day. Others use 30 2 mg chew-
ing gums/day but may not let them rest in-between chew-
ing, resulting in the nicotine being swallowed instead of
absorbed through the oral mucosa. Being able to use
NRT in places where smoking was prohibited has most
likely resulted in a pattern change from former smok-
ing habits to current NRT use. Therefore, even though
some use NRT excessively suggesting a certain degree
of habituation, the sustained use of NRT despite most
wishing to quit strengthens the belief that the found
association is actually based on dependence and not
habituation.
Long-term NRT use as a method for harm reduction?
Black et al. found that the presumptions among English
smokers were that using NRT is addictive and harmful
to health [23]. The findings in this study indicates that
http://www.harmreductionjournal.com/content/12/1/2
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addicted to NRT, and 40.9% of the respondents who stated
that they wished to quit NRT feared it to be harmful to
health. Only 12% of the respondents wished to continue
using NRT, primarily because they enjoyed using the
products and that it prevented possible relapse but also
because they appreciated NRT being less hazardous than
smoking. The scarcity of the respondents in this group
cannot lead to any firm conclusions, but those not wishing
to quit were mostly estimated to being low dependent,
which could be connected to the lack of concern, as they
may be more in control of their consumption than those
estimated to being highly dependent on NRT.
There are currently no free counselling offers available
in Denmark, for those long-term users wishing to quit
NRT. The only current offer is an online service, where
tapering out plans can be tailored according to the
degree of consumption, both for smoking cessation
and NRT use. This service is provided on behalf of the
Danish Cancer Society, the Danish Pharmacies Associ-
ation and The Danish Medicines and Health Agency
(http://ekvit.dk/).
Conclusion
The basic characteristics of the Danish long-term users
match those found in previous studies on long-term users
of NRT, but due to the study design, the generalizability of
the population cannot be validated. A significant majority
(88%) wished to quit NRT because of the cost of products,
being tired of feeling addicted and fear of adverse health
consequences. When applying the modified HSI, nicotine
dependence on NRT was estimated primarily to be mod-
erate to high. The strong association between TTFN and
NRT use found gives reason to believe the validity of the
modified HSI. Further studies are required for confirm-
ation. A significant equivalence ratio of 0.86:1 was found
when comparing current NRT use to recalled smoking,
for those smoking 25 or less cig/day, indicating that nico-
tine dependence is still present, but new patterns of use
concerning NRT may have replaced former smoking pat-
terns. Better counselling of long-term users on the benefits
of using NRT compared to smoking should be provided,
for those who are chronically dependent, as well as sup-
port to quit long-term use of NRT if requested.
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